Ignite Creation Date:
2025-12-25 @ 1:33 AM
Ignite Modification Date:
2026-03-03 @ 8:11 AM
Study NCT ID:
NCT05000294
Status:
SUSPENDED
Last Update Posted:
2025-10-15
First Post:
2021-08-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
Sponsor:
University of Florida
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-12-07
Start Date Type:
ACTUAL
Primary Completion Date:
2025-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-06
Completion Date Type:
ESTIMATED
First Submit Date:
2021-08-10
First Submit QC Date:
None
Study First Post Date:
2021-08-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-13
Last Update Post Date:
2025-10-15
Last Update Post Date Type:
ESTIMATED